National Association of Testing Authorities, Australia
Scope of Accreditation
Pathology Queensland
Site
Princess Alexandra Laboratory
Accreditation No.
2639
Site No.
2325
Date of Accreditation
10 Mar 1988
Contact
Mr Tony Sunner P: +61 0412191371
Availability
Services available to external clients
Supervision
GY (General)
Scope of Accreditation
Princess Alexandra Laboratory
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
01 Jul 2028
Last Activity Date
26 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Nipple discharge | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue; Fresh tissue; Smears | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue; Tissue imprint | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Fixed cytological smears; Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Detection of antigenic targets - Various | ||
| Formalin-fixed paraffin-embedded (FFPE) tissues; Frozen sections of fresh tissue | Detection of antigenic targets - Various | |
| Anatomical pathology - Tissue pathology - Mortuary facilities | Body; Body parts | Assessment - Level 2 mortuary |
| Anatomical pathology - Tissue pathology - Non-coronial autopsy services | Body; Body parts | Autopsy service and reporting |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Serum | Ethanol; Paracetamol (acetaminophen); Salicylate |
| Urine | Amphetamines; Benzodiazepines | |
| Buprenorphine; Cannabis; Cocaine; Methadone; Opiates | ||
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Carbamazepine; Gentamicin (cidomycin, septopal, genticyn, garamycin); Phenytoin (dilantin); Theophylline; Tobramycin; Valproate (valproic acid, epilim); Vancomycin |
| Methotrexate | ||
| Digoxin | ||
| Serum | Lithium | |
| Chemical pathology - Detection and/or quantitation of tumour markers | Ascitic fluid; Pleural fluid | Carcinoembryonic antigen (CEA) |
| Plasma; Serum | Carcinoembryonic antigen (CEA); α-Fetoprotein (AFP) | |
| Human chorionic gonadotropin (hCG) | ||
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma; Serum | Parathyroid hormone (PTH) |
| Cortisol | ||
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of cardiac function | Ascitic fluid; Pleural fluid | B-type natriuretic peptide (BNP) |
| Blood | Troponin I | |
| Plasma | B-type natriuretic peptide (BNP) | |
| Plasma; Serum | Troponin I | |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Haptoglobins |
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Bilirubin; Haemoglobin (Hb); Oxyhaemoglobin |
| Plasma | Haemoglobin (Hb) | |
| Plasma; Serum | Myoglobin | |
| Urine | Myoglobin | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Ascitic fluid; Pleural fluid | Alanine aminotransferase; Albumin; Alkaline phosphatase; Aspartate aminotransferase; Bilirubin - Total; Calcium - Total; Chloride; Cholesterol - Total; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Potassium; Protein - Total; Sodium; Triglycerides; γ-Glutamyltransferase |
| Blood | Anion gap; Calcium - Ionised; Chloride; Creatinine; Glucose; Potassium; Sodium; Total carbon dioxide (TCO2); Urea | |
| Creatinine | ||
| Cerebrospinal fluid (CSF) | Lactate dehydrogenase (LDH) | |
| Glucose; Lactate | ||
| Protein - Total | ||
| Peritoneal dialysis fluid | Calcium - Total; Chloride; Cholesterol - Total; Creatinine; Glucose; Lipase; Magnesium; Potassium; Sodium; Triglycerides; Urea | |
| Plasma | Ammonia; Lactate | |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Protein - Total; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Chloride; Potassium; Sodium | ||
| Plasma; Serum; Urine | Osmolality | |
| Pleural fluid | pH | |
| Serum | Indocyanine green clearance | |
| Urine | Protein - Total | |
| Ammonia; Bicarbonate | ||
| Blood; Glucose; Leucocyte esterase; Nitrite; Protein - Total; pH | ||
| Chloride; Potassium; Sodium | ||
| Albumin; Amylase; Calcium - Total; Creatinine; Glucose; Magnesium; Phosphate; Urate; Urea | ||
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studiesReporting only. Wet lab work performed by TRI - Proteomics Core Facility (21222 25540) | Formalin-fixed paraffin-embedded (FFPE) tissues | Amyloid forming proteins |
| Chemical pathology - Investigation for folate deficiency | Serum | Folate |
| Chemical pathology - Investigation of porphyria | Urine | Porphobilinogen (PBG) screen |
| Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; p50; pH |
| Base excess; Bicarbonate; Calcium - Ionised; Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total carbon dioxide (TCO2); pH | ||
| Chemical pathology - Quantitation of vitamins | Plasma; Serum | Cobalamin (vitamin B12) |
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material; Histological examination |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Cerebrospinal fluid (CSF) | Morphology | |
| Haematology - Full blood examination | Blood | Haematocrit (packed cell volume, PCV); Total haemoglobin - Calculated |
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes | ||
| Differential number; Morphology | ||
| Haemopoietic progenitor cells | Leucocyte count (white blood cell count, WBCC) | |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR); Prothrombin time (PT) |
| Platelet function (PFA) | ||
| Plasma | APTT heparin neutralisation; Activated partial thromboplastin time (APTT); Mixing studies - APTT; Thrombin time (TT) | |
| Echis test | ||
| Anti-Xa - Apixaban; Anti-Xa - Rivaroxaban; Anti-thrombin III; D-dimer; Factor IX; Factor VIII; Heparin assay; Heparin induced thrombocytopenia (HIT) - Confirmatory; Heparin induced thrombotic thrombocytopenia (HITT) | ||
| Activated partial thromboplastin time (APTT); International normalised ratio (INR) | ||
| Clauss fibrinogen; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Prothrombin time (PT); Reptilase time | ||
| Serum | Heparin induced thrombocytopenia (HIT) - Confirmatory | |
| Haematology - Investigation of haemolysis | Urine | Haemosiderin |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunohaematology - Blood group antibody detection | Blood; Plasma | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood; Plasma | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
| Blood; Plasma | Other blood group antibodies; Red blood cell phenotyping; Rh | |
| Plasma | Antibody titration | |
| Immunohaematology - Investigation of blood transfusion reactions | Blood; Blood products; Plasma | Antibodies; Contamination - Microbiological; Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Bone marrow; Cerebrospinal fluid (CSF); Disaggregated tissues specimen; Lavage; Serous fluid | Assessment of lymphoid cell populations; Assessment of myeloid cell populations; B-cell; CD10; CD103; CD117; CD11b; CD11c; CD123; CD13; CD138; CD14; CD15; CD16; CD19; CD1a; CD2; CD20; CD200; CD22; CD23; CD235a; CD24; CD25; CD3; CD30; CD33; CD34; CD38; CD4; CD41a; CD45; CD5; CD56; CD57; CD59; CD61; CD64; CD7; CD71; CD79a; CD8; Eosin-5-maleimide; FMC7; Fluorescein-labelled proaerolysin (FLAER); HLA-DR antigen; Immunoglobulin G2 (IgG2); Kappa light chains; Lambda light chains; MPO; Myeloperoxidase; Paroxysmal nocturnal haemoglobinuria (PNH) surface markers; T-cell receptor aβ (TCRab); T-cell receptor γδ (TCRgd); Terminal deoxynucleotidyl transferase (TdT); Total leucocyte number; Total lymphocyte number |
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProducts received from 17098-18678 | Haemopoietic progenitor cells | Clonogenic assays (culture) of harvested bone marrow/peripheral blood progenitor cells/cord blood stem cells; Processing; Storage (includes freezing/thawing) |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Plasma; Serum | Cryofibrinogen; Cryoglobulins |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Urine | Human chorionic gonadotropin (hCG) |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Bacterial isolates | Carbapenem resistant Enterobacteriaceae (CRE); Carbapenem resistant Pseudomonas aeruginosa (CRP) |
| Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Operative specimens; Respiratory specimens; Tissues; Urine | Bacteria; Pathogenic identification; Pathogenic microorganisms | |
| Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
| Bacteria; Pathogenic microorganisms | ||
| Antibiotic susceptibility | ||
| Faeces | Clostridioides difficile toxin | |
| Synovial fluid | Crystals | |
| Urine | Legionella antigen; Streptococcus pneumoniae antigen | |
| Albumin; Bilirubin; Blood; Creatinine; Glucose; Ketones; Leucocytes (white blood cells, WBC); Nitrite; Proteins; Specific gravity; Urobilinogen; pH | ||
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Air; Environmental swabs; Spore strips | Bacterial growth - Sterility |
| Blood transfusion bags; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial organism identification - Acinetobacter; Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) | |
| Bacterial growth - Sterility | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates | Van A/B |
| Bacterial isolates; Rectal swabs | CarbaR | |
| Nasopharyngeal swabs | Methicillin resistant Staphylococcus aureus (MRSA) | |
| Rectal swabs | Van A/B | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Plasmodium spp. |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Aspirates; Bronchial washings; Lavage; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Oropharyngeal swabs; Washings | Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV); Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasal swabs; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasopharyngeal swabs | Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV); Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | ||
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Other body fluids; Respiratory specimens; Sputum; Urine | Mycobacteria identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Blood; Cerebrospinal fluid (CSF); Hair; Nails; Skin scrapings; Tissues; Urine | Fungi susceptibility; Yeast susceptibility |
| Fungi identification; Yeasts identification | ||
| Fungi identification; Yeasts identification | ||
| Fungi identification; Yeasts identification | ||
| Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Genital swabs; Urine | Trichomonad | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood; Plasma; Serum | Infectious mononucleosis |
| Plasma; Serum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody | |
| Hepatitis A virus (HAV); Hepatitis B virus (HBV); Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Human immunodeficiency virus (HIV); Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Rubella IgG antibody; Syphilis Treponema pallidum antibody | ||
| Serum | Syphilis Treponema pallidum antibody | |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood; Bone marrow; Extracted DNA | Blood borne tumours |
| Blood borne tumours | ||
| Blood borne tumours | ||
| Blood borne tumours | ||
| Blood; Bone marrow; Extracted RNA | Blood borne tumours | |
| Blood borne tumours | ||
| Blood borne tumours | ||
| Blood borne tumours | ||
| Molecular genetics - DNA extraction | Blood; Bone; Bone marrow; Cerebrospinal fluid (CSF); Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue; Frozen tissue; Skin biopsy; Tissues; Trephine | DNA storage for future analyses; Viable DNA; Viable DNA for sequencing and other molecular assays |
| Extracted DNA | Quantification of DNA | |
| Molecular genetics - RNA extraction | Blood; Bone marrow | RNA storage for future analyses; Viable RNA; Viable RNA for molecular diagnostics; Viable RNA for sequencing |
Day Surgery
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jul 2028
Last Activity Date
26 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total carbon dioxide (TCO2); pH |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen)2 x RAPIDPoint 500's | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; p50; pH |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR); Prothrombin time (PT) |
Emergency Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jul 2028
Last Activity Date
26 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen)2 x RAPIDPoint 500's | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; p50; pH |
Emergency Department Care PACT nursing home
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jul 2028
Last Activity Date
26 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Further investigation of cardiac function | Blood | Troponin I |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Anion gap; Calcium - Ionised; Chloride; Creatinine; Glucose; Potassium; Sodium; Total carbon dioxide (TCO2); Urea |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Lactate; Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Total carbon dioxide (TCO2); pH |
| Haematology - Full blood examination | Blood | Haematocrit (packed cell volume, PCV); Haemoglobin (Hb) |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR); Prothrombin time (PT) |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jul 2028
Last Activity Date
26 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen)3 x RAPIDPoint500's | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; p50; pH |
Radiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jul 2028
Last Activity Date
26 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Creatinine |
Respiratory Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jul 2028
Last Activity Date
26 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total carbon dioxide (TCO2); pH |
Theatres
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jul 2028
Last Activity Date
26 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen)2 x RAPIDPoint 500's | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; p50; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2639
Site No.
2325
Print date
26 Nov 2024
END OF SCOPE